UFCW Canada lifetime fundraising for Leukemia & Lymphoma Society of Canada tops $49 million thanks to $1.86 million campaign in 2021-2022
June 17, 2022 13:22 ET
|
UFCW Canada
TORONTO, June 17, 2022 (GLOBE NEWSWIRE) -- Another year of pandemic restrictions presented unique challenges for UFCW Canada’s fundraising efforts on behalf of the Leukemia & Lymphoma Society...
$4.31 Billion Worldwide Hematology Analyzers and Reagents Industry to 2030 - Identify Growth Segments for Investment
December 30, 2021 05:33 ET
|
Research and Markets
Dublin, Dec. 30, 2021 (GLOBE NEWSWIRE) -- The "Hematology Analyzers and Reagents Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's...
$2.1 million campaign pushes UFCW Canada lifetime fundraising for The Leukemia & Lymphoma Society of Canada past $47.2 million
July 26, 2021 15:48 ET
|
UFCW Canada; The Leukemia & Lymphoma Society of Canada
TORONTO, July 26, 2021 (GLOBE NEWSWIRE) -- Despite an extraordinarily challenging year, UFCW Canada members and Local Unions were undeterred in their extraordinary ongoing fundraising efforts,...
Alliance for Regenerative Medicine Responds to EU Beating Cancer Plan
February 03, 2021 09:00 ET
|
The Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Responds to EU Beating Cancer Plan ATMPs are uniquely positioned to attack cancer at its source, bringing life-changing benefits to patients BRUSSELS, BELGIUM –...
MEDIA ADVISORY: Major donation from UFCW Canada to be presented June 13 to Leukemia and Lymphoma Society of Canada to accelerate advancements in blood cancer treatments
June 12, 2018 16:32 ET
|
UFCW Canada
TORONTO, June 12, 2018 (GLOBE NEWSWIRE) -- On Wednesday, June 13, 2018, UFCW Canada (United Food and Commercial Workers union) will be presenting its annual fundraising donation to the Leukemia and...
Kura Oncology Announces Presentation of Preliminary Clinical Data for Tipifarnib in HRAS Mutant Squamous Cell Carcinomas of the Head and Neck at TAT 2017
February 27, 2017 07:30 ET
|
Kura Oncology, Inc.
LA JOLLA, Calif., Feb. 27, 2017 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq:KURA), a clinical stage biopharmaceutical company, today announced an oral presentation for its lead product...
Kura Oncology to Present at the Jefferies 2015 Global Healthcare Conference
May 27, 2015 07:30 ET
|
Kura Oncology, Inc.
LA JOLLA, Calif., May 27, 2015 (GLOBE NEWSWIRE) -- Kura Oncology, Inc., a clinical stage biopharmaceutical company advancing a pipeline of precision medicines for the treatment of solid tumors and...